Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Europe
Published
2024-10-07
DOI
https://doi.org/10.1016/j.lanepe.2024.101092
Citations
22
Primary Topic
Neurogenetic and Muscular Disorders Research
Type
article
Field-Weighted Citation Impact
9.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study

Ralf A. Husain, Matthias Baumann, Marina Flotats‐Bastardas, Ekkehard Wilichowski et al.
22 citations
The Lancet Regional Health - Europe
Neurogenetic and Muscular Disorders Research
9.63
article

Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study

Ralf A. Husain, Matthias Baumann, Marina Flotats‐Bastardas, Ekkehard Wilichowski, Klaus Goldhahn, Janbernd Kirschner, Andrea Klein, Astrid Eisenkölbl, Veronka Horber, Regina Trollmann, Sebahattin Çırak, Andreas Ziegler, Georg Martin Stettner, Johannes Friese, Andreas Hahn, Gudrun Schreiber, Sabine Illsinger, Astrid Blaschek, Jessika Johannsen, Günther Bernert, Maja von der Hagen, Oswald Hasselmann, Lena‐Luise Becker, Barbara Plecko, Angela M. Kaindl, Sven F. Garbade, Cornelia Köhler, Claudia Weiß, Astrid Pechmann, Oliver Schwartz, Ulrike Schara
article en
22 citations

Abstract

No abstract available for this paper.
The Lancet Regional Health - EuropeVol. 47
University of Bern (CH), Johannes Kepler University of Linz (AT), Innsbruck Medical University (AT), Universität Hamburg (DE), University of Freiburg (DE), University of Mannheim (DE), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Universität Ulm (DE), Medical University of Graz (AT), Heidelberg University (DE), University Hospital Bonn (DE), University Hospitals of the Ruhr-University of Bochum (DE), University Hospital of Bern (CH), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), Medizinische Hochschule Hannover (DE), Universitätsklinikum des Saarlandes (DE), University Hospital Münster (DE), University Medical Center Hamburg-Eppendorf (DE), Kepler Universitätsklinikum (AT), University Children's Hospital Tübingen (DE), University Children's Hospital Zurich (CH), DRK Kliniken Berlin (DE), Jena University Hospital (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Klinikum Kassel (DE), LWL-Universitätsklinikum Bochum (DE), University Hospital Carl Gustav Carus (DE), Technische Hochschule Ulm (DE), SBA Research (AT), University of Duisburg-Essen (DE), University of Göttingen (DE), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE)
Pfizer, Biogen, Stiftung für die Erforschung der Muskelkrankheiten, PTC Therapeutics, AveXis, Sarepta Therapeutics, Deutsche Gesellschaft für Muskelkranke
Zero hunger
Openalex Percentile: Top 1%
Neurogenetic and Muscular Disorders Research
9.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.